Access cutting-edge breast cancer treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cancer that is estrogen receptor positive (ER+) and human epidermal receptor 2 negative (HER2-). Participants must have already taken endocrine therapy for two to five years and must have a higher-than-average risk for their cancer to return. Study participation could last up to 10 years.
Sponsor: Eli Lilly and Company
Check if you qualify for this breast cancer clinical trial in Phoenix, AZ
If you're searching for breast cancer treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.